TRASICOR TAB 40MG DIN 00402575
Status: Cancelled Post Market
Holder: NOVARTIS PHARMACEUTICALS CANADA INC
Molecule: OXPRENOLOL HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | OXPRENOLOL HYDROCHLORIDE 40 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C07AA02 OXPRENOLOL |
| Original market date | 31-Dec-1980 |
| Current status date | 22-Jan-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Novartis Pharmaceuticals Canada Inc — licence 100273, currently licensed, last inspection rating C (2025-01-14).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXPRENOLOL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00534587 | SLOW TRASICOR TAB 160MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Extended-Release) | OXPRENOLOL HYDROCHLORIDE 160 MG | Cancelled Post Market |
| 00534579 | SLOW TRASICOR TAB 80MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Extended-Release) | OXPRENOLOL HYDROCHLORIDE 80 MG | Cancelled Post Market |
| 00402567 | TRASICOR TAB 20MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | OXPRENOLOL HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 00402583 | TRASICOR TAB 80MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | OXPRENOLOL HYDROCHLORIDE 80 MG | Cancelled Post Market |